Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells

Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells

US Patent 11008557 · Granted May 18, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods of use for small-molecule regulation of CRISPR-Cas9 act2025
CFTR-modulating compositions and methods2025
Nucleic acid-guided nucleases2025
Nucleic acid-guided nucleases2024
Delivery of therapeutics in vivo via a CRISPR-based cascade system2024
Engineered nucleic acid-guided nucleases2024
Detection of nucleic acid and non-nucleic acid target molecules2024
Compositions and methods for improved gene editing2024
Dual strand nucleic acid-guided nickase editing2024
CRISPR/Cas activity assays and compositions thereof2023
CRISPR enabled multiplexed genome engineering2023
Instruments, modules, and methods for improved detection of edited sequences in 2023